Results 131 to 140 of about 116,083 (186)

Case Report: Metastasis to pleura and mediastinal lymph nodes from breast secretory carcinoma: 10 years follow-up. [PDF]

Front Oncol
Huang F, Zhao J, Lian J, Hong B, Yu X, Ma X, Lai J, Qian W, Tu J, Qiu F, Zou H, Huang J, Li J.   +12 more
europepmc   +1 more source

NTRK-rearranged spindle cell neoplasm of the female genital tract: case report and literature review. [PDF]

Front Oncol
Feng L, Li L, He Y, Jiang W.
europepmc   +1 more source

Selective Modulation of Trk Receptors by <i>Cyclo</i>-Organopeptides. [PDF]

ACS Chem Neurosci
Joy S, Mi T, Lyu RL, Pewklang T, Thompson T, Sefiani A, Kamkaew A, Burgess K.   +7 more
europepmc   +1 more source

Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. [PDF]

Cancer Res Commun
Cassier PA, Borad MJ, Sharma S, Dubois B, Caux C, Okano F, Von Hoff DD, Blay JY.   +7 more
europepmc   +1 more source

Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion. [PDF]

NPJ Precis Oncol
Keane S, Sjöberg I, Deland L, Lindlöf A, Bontell TO, Kling T, Blomstrand M, Fagman H, Nilsson JA, Nilsson D, Sabel M, Carén H, Abel F.   +12 more
europepmc   +1 more source

TRK Inhibitors in Adult and Pediatric High-Grade Gliomas: A Systematic Review and Individual Participant Data Meta-Analysis. [PDF]

Cancers (Basel)
Rizzaro MD, Fanizzi C, Fiore G, Remore LG, Ampollini AM, Pluderi M, Caroli M, Locatelli M.   +7 more
europepmc   +1 more source

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review. [PDF]

Curr Oncol
Bischoff H, Gendarme S, Somme L, Chouaid C, Schott R.   +4 more
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

A plain language summary of two trials for larotrectinib in people with TRK fusion-positive lung cancer to learn how well the drug works and how safe it is. [PDF]

Future Oncol
Drilon A, Lin JJ, Burcoveanu DI, Ollis C, Reiss M, Torberger O, Moreno V.   +6 more
europepmc   +1 more source

Lipofibromatosis Revisited. [PDF]

In Vivo
Shinohara Y, Nishio J, Nakayama S, Aoki M.   +3 more
europepmc   +1 more source